These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Telomere shortening in neurological disorders: an abundance of unanswered questions. Eitan E; Hutchison ER; Mattson MP Trends Neurosci; 2014 May; 37(5):256-63. PubMed ID: 24698125 [TBL] [Abstract][Full Text] [Related]
4. Relationship between telomere shortening and age in Korean individuals with mild cognitive impairment and Alzheimer's disease compared to that in healthy controls. Lee EH; Han MH; Ha J; Park HH; Koh SH; Choi SH; Lee JH Aging (Albany NY); 2020 Dec; 13(2):2089-2100. PubMed ID: 33323554 [TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of Telomere Length in Alzheimer's Disease. Forero DA; González-Giraldo Y; López-Quintero C; Castro-Vega LJ; Barreto GE; Perry G J Gerontol A Biol Sci Med Sci; 2016 Aug; 71(8):1069-73. PubMed ID: 27091133 [TBL] [Abstract][Full Text] [Related]
6. Telomere length in Parkinson's disease: A meta-analysis. Forero DA; González-Giraldo Y; López-Quintero C; Castro-Vega LJ; Barreto GE; Perry G Exp Gerontol; 2016 Mar; 75():53-5. PubMed ID: 26772888 [TBL] [Abstract][Full Text] [Related]
7. Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Orrù G; Pettersson-Yeo W; Marquand AF; Sartori G; Mechelli A Neurosci Biobehav Rev; 2012 Apr; 36(4):1140-52. PubMed ID: 22305994 [TBL] [Abstract][Full Text] [Related]
8. [Accelerated telomere erosion in schizophrenia: A literature review]. Corfdir C; Pignon B; Szöke A; Schürhoff F Encephale; 2021 Aug; 47(4):369-375. PubMed ID: 33863507 [TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapeutic Considerations on Telomere Biology: The Positive Effect of Pharmacologically Active Substances on Telomere Length. Apetroaei MM; Fragkiadaki P; Velescu BȘ; Baliou S; Renieri E; Dinu-Pirvu CE; Drăgănescu D; Vlăsceanu AM; Nedea MII; Udeanu DI; Docea AO; Tsatsakis A; Arsene AL Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062937 [TBL] [Abstract][Full Text] [Related]
10. Leukocyte telomere length in patients with schizophrenia: A meta-analysis. Polho GB; De-Paula VJ; Cardillo G; dos Santos B; Kerr DS Schizophr Res; 2015 Jul; 165(2-3):195-200. PubMed ID: 25975826 [TBL] [Abstract][Full Text] [Related]
11. Long leukocyte telomere length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism. Degerman S; Domellöf M; Landfors M; Linder J; Lundin M; Haraldsson S; Elgh E; Roos G; Forsgren L PLoS One; 2014; 9(12):e113387. PubMed ID: 25501556 [TBL] [Abstract][Full Text] [Related]
12. No alteration of leukocyte telomere length in first episode psychosis. Schürhoff F; Corfdir C; Pignon B; Lajnef M; Richard JR; Marcos E; Pelissolo A; Leboyer M; Adnot S; Jamain S; Szöke A Psychiatry Res; 2021 Jul; 301():113941. PubMed ID: 33945962 [TBL] [Abstract][Full Text] [Related]
13. Hormone-brain-aging relationships, broadly reactive with imidazole-containing dipeptides: targeting of telomere attrition as an aging biomarker and dynamic telomerase activity flirting. Babizhayev MA; Vishnyakova KS; Yegorov YE J Basic Clin Physiol Pharmacol; 2015 Mar; 26(2):115-40. PubMed ID: 25153587 [TBL] [Abstract][Full Text] [Related]
14. The potential impact of biochemical mediators on telomere attrition in major depressive disorder and implications for future study designs: A narrative review. Manoliu A; Bosch OG; Brakowski J; Brühl AB; Seifritz E J Affect Disord; 2018 Jan; 225():630-646. PubMed ID: 28889049 [TBL] [Abstract][Full Text] [Related]
15. The use of telomere length as a predictive biomarker for injury prognosis in juvenile rats following a concussion/mild traumatic brain injury. Hehar H; Mychasiuk R Neurobiol Dis; 2016 Mar; 87():11-8. PubMed ID: 26709201 [TBL] [Abstract][Full Text] [Related]